[Form 4] Crown Crafts Inc Insider Trading Activity

Rhea-AI Filing Summary

MiMedx Group, Inc. (MDXG) – Form 4 insider filing: Chief Financial Officer Doug Rice reported a Rule 16b-3 Code F transaction on 07/03/2025 related to the vesting of restricted stock units. A total of 12,749 common shares were withheld and disposed at a price of $6.34 per share to satisfy tax-withholding obligations. Following the transaction, Rice’s direct ownership stands at 188,024 shares.

The disposition was not an open-market sale; Code F denotes tax-payment with shares, a routine administrative event. There were no derivative security transactions disclosed and no indication of a 10b5-1 trading plan. The filing does not signal a strategic change in position but updates Rice’s beneficial ownership after the equity award’s vesting.

Positive

• None.

Negative

• CFO’s share count decreased by 12,749 shares (≈6% of his prior direct holdings) due to tax-withholding, marginally reducing insider ownership.

Insights

Securities Analyst

TL;DR: Routine tax-withholding reduces CFO’s stake by ~6%, minimal market impact.

The Form 4 shows a standard administrative disposition. Rice relinquished 12,749 shares (≈$0.08 million) to cover taxes on vested RSUs, leaving 188,024 shares. Code F confirms no discretionary selling. The transaction amounts to roughly 6% of his pre-transaction holdings, immaterial to MiMedx’s float. Investors should not read this as a bearish signal; it is common after equity awards vest. No derivatives, 10b5-1 plan, or pattern of selling is indicated, so overall impact is neutral.

Corporate Governance Expert

TL;DR: Filing reflects compliance with Section 16; no governance red flags.

The timely Form 4 demonstrates management’s adherence to disclosure rules. Code F filings are expected when RSUs vest. The CFO still retains a substantive equity stake (≈$1.2 million at $6.34), maintaining alignment with shareholder interests. No joint filings or large-scale disposals appear, and the single-line reporting format suggests straightforward ownership. Accordingly, the event is governance-neutral and not considered materially impactful to shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Demarest Craig

(Last) (First) (Middle)

PO BOX 1028

(Street)

GONZALES LA 70707-1028

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CROWN CRAFTS INC [ CRWS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President and CFO

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2025		F(1)		3,103	D	$2.89	45,262	D
Common Stock	07/02/2025		D(2)		14,429	D	$0	30,833	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction represents the surrender to the Issuer by the Reporting Person of 3,103 shares of common stock to satisfy the tax withholding obligations incurred by the Reporting Person upon the vesting of 10,571 shares of common stock awarded to the Reporting Person on March 26, 2024.

2. This transaction represents the forfeiture to the Issuer by the Reporting Person of 14,429 shares of common stock awarded to the Reporting Person on March 26, 2024.

Remarks:

In connection with the retirement from all positions that the Reporting Person held with the Issuer, the Compensation Committee of the Board of Directors of the Issuer accelerated the vesting of a portion of the total quantity of 25,000 shares of common stock awarded to the Reporting Person on March 26, 2024, such award originally scheduled to vest in its entirety on March 26, 2027. Pursuant to such acceleration, 10,571 shares of common stock vested effective as of the last day of the Reporting Person's employment with the Issuer on July 2, 2025, such quantity of shares of common stock vested calculated as the product of (i) 25,000, multiplied by (ii) a fraction, the numerator of which is the number of calendar days that the Reporting Person was employed by the Issuer from March 26, 2024 through July 2, 2025 and the denominator of which is the number of calendar days in the original vesting period of March 26, 2024 through March 26, 2027. The remaining unvested portion of the award, consisting of 14,429 shares of common stock and calculated as the difference between the 25,000 shares of common stock originally awarded to the Reporting Person on March 26, 2024 and the 10,571 shares of common stock from such award that vested on the last day of the Reporting Person's employment with the Issuer on July 2, 2025, were forfeited to the Issuer.

	/s/ Daniel W. Miller, on behalf of Craig Demarest	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MiMedx CFO Doug Rice report in the latest Form 4?

He disclosed the withholding and disposal of 12,749 common shares on 07/03/2025 to cover taxes on vested RSUs.

At what price were the MiMedx shares disposed?

The shares were valued at $6.34 per share, as stated in the filing.

How many MiMedx shares does the CFO now own?

After the transaction, Doug Rice directly owns 188,024 shares of MDXG common stock.

What does Transaction Code F mean in a Form 4?

Code F indicates shares were withheld to pay taxes on equity award vesting, not an open-market sale.

Was a Rule 10b5-1 plan involved in this transaction?

No; the filing does not reference a 10b5-1 plan, implying a routine administrative action.

Does the filing suggest the CFO is selling MDXG shares voluntarily?

No; the shares were automatically withheld for tax purposes, so it does not signal discretionary selling.